Showing results (491-500 of 611) with videos related to
Sort By:
Pageof 62
Journal of Medicinal Chemistry|December 7, 2019
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry InhibitorsBelén Martínez-Gualda, Liang Sun, Olaia Martí-Marí, et al.Journal of Medicinal Chemistry|January 16, 2025
Structure-Based Optimization of Pyridone α-Ketoamides as Inhibitors of the SARS-CoV-2 Main ProteaseRavi Kumar Akula, Haifa El Kilani, Alina Metzen, et al.Chemistry & Biology|January 27, 2015
Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infectionMagnus Joakim Hansson, Steven James Moss, Michael Bobardt, et al.Nature Communications|July 19, 2024
Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formationDominik Kiemel, Ann-Sophie Helene Kroell, Solène Denolly, et al.Antiviral Research|January 16, 2017
Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307Lucian Albulescu, Joëlle Bigay, Bishyajit Biswas, et al.Ebiomedicine|August 30, 2022
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster modelsJi Ma, Michael Bright Yakass, Sander Jansen, et al.Nature Communications|February 16, 2022
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concernRana Abdelnabi, Caroline S Foo, Dirk Jochmans, et al.Journal of Medicinal Chemistry|January 26, 2017
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary DiseasesSabrina Tassini, Liang Sun, Kristina Lanko, et al.Antiviral Research|January 18, 2011
Picornavirus non-structural proteins as targets for new anti-virals with broad activityHeléne Norder, Armando M De Palma, Barbara Selisko, et al.The Lancet. Infectious Diseases|July 12, 2017
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling studyMami Taniuchi, Michael Famulare, Khalequ Zaman, et al.Pageof 62